| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |